Search Press releases Keywords From To 19 Jan 2017 Final CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Primary Efficacy Endpoint in Patients with Moderate-to-Severe Chronic Plaque Psoriasis Read More 19 Jan 2017 UCB files BRIVIACT® (brivaracetam) CV in the U.S. as monotherapy treatment for adult epilepsy patients with partial-onset seizures Read More 16 Jan 2017 Transparency notification Read More 12 Jan 2017 Transparency notification Read More 9 Jan 2017 Transparency notification Read More 9 Jan 2017 Transparency Notification Read More Pagination First page Previous page Previous … Page 83 Page 84 Page 85 Page 86 Current page 87 Page 88 Page 89 Page 90 Page 91 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
